Owen Catherine E. Insider Profile
4 Followers
Owen Catherine E., Director at Optinose, holds ― shares in Optinose (Ticker: OPTN), holds 14.80K shares in ACADIA Pharmaceuticals (Ticker: ACAD), holds 6.07K shares in Agios Pharma (Ticker: AGIO). Most recently, Owen Catherine E. ― shares of Optinose on ― for an estimated value of ―.
Owen Catherine E. Optinose (OPTN)Director
Optinose (OPTN)
Director
Not Ranked
Owen Catherine E. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Owen Catherine E. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Owen Catherine E.
Owen Catherine E.'s Trading History
Optinose
―
―
―
―
Agios Pharma
Jun 23, 2025
Director
Uninformative Buy
72.95K
$170.89K
ACADIA Pharmaceuticals
Mar 26, 2026
CEO, Director
Uninformative Buy
248.75K
$312.34K
List of latest transactions for each holding click on a transaction to see Owen Catherine E.'s performance on stock
You May Also Like
Owen Catherine E. insider profile FAQ
What is the percentage of profitable transactions made by Owen Catherine E.?
The percentage of profitable transactions made by Owen Catherine E. is ―.
What is the average return per transaction made by Owen Catherine E.?
The average return per transaction made by Owen Catherine E. is ―.
What stocks does Owen Catherine E. hold?
Owen Catherine E. holds: OPTN, AGIO, ACAD stocks.
What was Owen Catherine E.’s latest transaction?
Owen Catherine E. latest transaction was an Uninformative Buy of ―.
What was Owen Catherine E.'s most profitable transaction?
Owen Catherine E.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Owen Catherine E.'s role in Optinose?
Owen Catherine E.'s role in Optinose is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.